These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31077447)

  • 1. Engrailed-1 induces long-lasting behavior benefit in an experimental Parkinson primate model.
    Thomasson N; Pioli E; Friedel C; Monseur A; Lavaur J; Moya KL; Bezard E; Bousseau A; Prochiantz A
    Mov Disord; 2019 Jul; 34(7):1082-1084. PubMed ID: 31077447
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in Activity-Dependent Neuroprotective Protein in Sporadic and Experimental Parkinson's Disease.
    Chu Y; Morfini GA; Kordower JH
    J Parkinsons Dis; 2016; 6(1):77-97. PubMed ID: 27003787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology. Chaperones take flight.
    Helfand SL
    Science; 2002 Feb; 295(5556):809-10. PubMed ID: 11823628
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease.
    Kumari N; Agrawal S; Kumari R; Sharma D; Luthra PM
    Neurosci Lett; 2018 May; 675():74-82. PubMed ID: 29567422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model.
    Blanchet PJ; Calon F; Morissette M; Goulet M; Grondin R; Lévesque D; Bédard PJ; Di Paolo T
    Adv Neurol; 2001; 86():337-44. PubMed ID: 11553994
    [No Abstract]   [Full Text] [Related]  

  • 6. Histamine-4 receptor antagonist JNJ7777120 inhibits pro-inflammatory microglia and prevents the progression of Parkinson-like pathology and behaviour in a rat model.
    Zhou P; Homberg JR; Fang Q; Wang J; Li W; Meng X; Shen J; Luan Y; Liao P; Swaab DF; Shan L; Liu C
    Brain Behav Immun; 2019 Feb; 76():61-73. PubMed ID: 30408497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys.
    Julien C; Berthiaume L; Hadj-Tahar A; Rajput AH; Bédard PJ; Di Paolo T; Julien P; Calon F
    Neurochem Int; 2006 Apr; 48(5):404-14. PubMed ID: 16442670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational research for Parkinson׳s disease: The value of pre-clinical primate models.
    Aron Badin R; Vadori M; Cozzi E; Hantraye P
    Eur J Pharmacol; 2015 Jul; 759():118-26. PubMed ID: 25841877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons.
    Albéri L; Sgadò P; Simon HH
    Development; 2004 Jul; 131(13):3229-36. PubMed ID: 15175251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease pathogenesis from the viewpoint of small fish models.
    Matsui H; Takahashi R
    J Neural Transm (Vienna); 2018 Jan; 125(1):25-33. PubMed ID: 28770388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPECT imaging, immunohistochemical and behavioural correlations in the primate models of Parkinson's disease.
    Ashkan K; Wallace BA; Mitrofanis J; Pollo C; Brard PY; Fagret D; Benabid AL
    Parkinsonism Relat Disord; 2007 Jul; 13(5):266-75. PubMed ID: 17196871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin hyperinnervation of the striatum with high synaptic incidence in parkinsonian monkeys.
    Gagnon D; Gregoire L; Di Paolo T; Parent M
    Brain Struct Funct; 2016 Sep; 221(7):3675-91. PubMed ID: 26462663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.
    Bazzu G; Calia G; Puggioni G; Spissu Y; Rocchitta G; Debetto P; Grigoletto J; Zusso M; Migheli R; Serra PA; Desole MS; Miele E
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):482-90. PubMed ID: 20522009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance spectroscopy in Parkinson's disease and parkinsonian syndromes.
    Rango M; Arighi A; Biondetti P; Barberis B; Bonifati C; Blandini F; Pacchetti C; Martignoni E; Bresolin N; Nappi G
    Funct Neurol; 2007; 22(2):75-9. PubMed ID: 17637209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.
    Liu B; Dluzen DE
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Engrailed mutant mice as experimental models for Parkinson's disease.
    Sgadò P; Viaggi C; Fantacci C; Corsini GU
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S103-6. PubMed ID: 18585948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aucubin alleviates glial cell activation and preserves dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian mice.
    Zhu YL; Sun MF; Jia XB; Zhang PH; Xu YD; Zhou ZL; Xu ZH; Cui C; Chen X; Yang XS; Shen YQ
    Neuroreport; 2018 Sep; 29(13):1075-1083. PubMed ID: 29985188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiol Oxidation by Diamide Leads to Dopaminergic Degeneration and Parkinsonism Phenotype in Mice: A Model for Parkinson's Disease.
    Ray A; Kambali M; Ravindranath V
    Antioxid Redox Signal; 2016 Aug; 25(5):252-67. PubMed ID: 27121974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-human primate model for stable chronic Parkinson's disease induced by MPTP administration based on individual behavioral quantification.
    Seo J; Lee Y; Kim BS; Park J; Yang S; Yoon HJ; Yoo J; Park HS; Hong JJ; Koo BS; Baek SH; Jeon CY; Huh JW; Kim YH; Park SJ; Won J; Ahn YJ; Kim K; Jeong KJ; Kang P; Lee DS; Lim SM; Jin YB; Lee SR
    J Neurosci Methods; 2019 Jan; 311():277-287. PubMed ID: 30391524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.
    Kordower JH; Emborg ME; Bloch J; Ma SY; Chu Y; Leventhal L; McBride J; Chen EY; Palfi S; Roitberg BZ; Brown WD; Holden JE; Pyzalski R; Taylor MD; Carvey P; Ling Z; Trono D; Hantraye P; Déglon N; Aebischer P
    Science; 2000 Oct; 290(5492):767-73. PubMed ID: 11052933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.